ArticleFrontiers in neurology2026
Multifactorial stratified analysis of two novel metabolism-related indices for predicting stroke in mild cognitive impairment.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the predictive value of two novel metabo-lism-related indices, the C-reactive protein-triglyceride glucose index (CTI) and the Body Roundness Index (BRI), for new-onset stroke in patients with mild cognitive impairment (MCI). A systematic stratified analysis based on various factors was con-ducted to refine clinical strategies for the primary prevention of stroke. Methods: Data were obtained from the China Health and Retirement Longitudinal Study (CHARLS). A total of 907 eligible participants were included in this cohort study. Multivariable logistic regression models were employed to assess the associations of CTI and BRI with stroke risk. Exploratory stratified analyses were performed using piecewise linear regression and receiver operating characteristic (ROC) curves based on key behavioral and demographic characteristics, with optimal cutoff values calculated for each stratum. Subgroup analyses were conducted to verify the stability of the findings. Results: During the follow-up period, 81 participants (8.93%) experienced a stroke. After adjusting for potential confounding factors, each one-unit increase in CTI was associated with a 34% higher risk of stroke among MCI patients (Odds Ratio (OR): 1.34, 95% Confidence Interval (CI): 1.04-1.72, Conclusion: Among middle-aged and elderly Chinese patients with MCI, CTI predicts stroke risk better than BRI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.